|
FXR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.372400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.790190E-01 |
| Normal-vs-Stage2 |
9.016800E-01 |
| Normal-vs-Stage3 |
8.298100E-02 |
| Normal-vs-Stage4 |
8.399500E-02 |
| Stage1-vs-Stage2 |
3.768600E-01 |
| Stage1-vs-Stage3 |
3.397600E-03 |
| Stage1-vs-Stage4 |
5.235800E-03 |
| Stage2-vs-Stage3 |
1.998560E-01 |
| Stage2-vs-Stage4 |
8.614200E-02 |
| Stage3-vs-Stage4 |
5.617000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.481000E-01 |
| Normal-vs-AfricanAmerican |
8.364800E-01 |
| Normal-vs-Asian |
4.482000E-01 |
| Caucasian-vs-AfricanAmerican |
4.185200E-01 |
| Caucasian-vs-Asian |
4.510600E-01 |
| AfricanAmerican-vs-Asian |
3.002200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.346400E-01 |
| Normal-vs-Female |
3.019800E-03 |
| Male-vs-Female |
8.34499999999849E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.031800E-01 |
| Normal-vs-Extreme_Weight |
3.232400E-01 |
| Normal-vs-Obese |
4.263600E-01 |
| Normal-vs-Extreme_Obese |
8.476000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.614800E-01 |
| Normal_Weight-vs-Obese |
7.895600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.884600E-01 |
| Extreme_Weight-vs-Obese |
1.088990E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.102800E-01 |
| Obese-vs-Extreme_Obese |
8.877400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.274290E-02 |
| Normal-vs-Age(41-60Yrs) |
2.085400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.412000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.642800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.128400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.777600E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.016400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.889800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.393350E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.021000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.161400E-01 |
| Normal-VS-Type2 PRCC |
3.360600E-01 |
| Normal-VS-KIRP CIMP |
1.80569999952418E-07 |
| Normal-VS-Unclassified PRCC |
3.330800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.023960E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.54292999999806E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.261410E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.923600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.523600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.843000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.652400E-01 |
| Normal-vs-N1 |
1.628130E-04 |
| Normal-vs-N2 |
2.437000E-01 |
| N0-vs-N1 |
2.51090000003007E-06 |
| N0-vs-N2 |
2.165200E-01 |
| N1-vs-N2 |
7.575200E-01 |
|
|
